ArticleScientific reports2025
Comparison of oxidative stress status in the kidney tissue of male rats treated with paraquat and nanoparaquat.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Extracorporeal therapies in the management of paraquat poisoning: a comprehensive review of current evidence.Annals of medicine · 2026Review
- The molecular mechanism of the protective effect of tianeptine against ovarian ischemia-reperfusion injury.Scientific reports · 2025Article
- Berberine Extends Lifespan inAntioxidants (Basel, Switzerland) · 2025Article
- Bromhexine hydrochloride enhances the therapeutic efficacy of tiamulin against experimentalFrontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to compare the oxidative stress status in the kidney tissue of rats treated with paraquat and nanoparaquat. The levels of oxidative stress markers, including malondialdehyde (MDA), total antioxidant capacity (TAC), and thiol groups (TTG), were measured in the kidney tissue samples. A total of forty male Wistar rats were randomly assigned to eight groups, each consisting of five rats: a control group, a paraquat (PQ) group, an N-acetylcysteine (NAC) group, groups receiving nanoparaquat α and β (α and β), groups receiving PQ and NAC (PQ + NAC), and groups receiving nanoparaquat α and β with NAC (+ NACα and β). Paraquat, a widely used herbicide, induces severe oxidative damage in kidneys through radical formation and cellular stress. Newly developed nanoparaquat formulations may modify its toxicity profile and tissue distribution patterns. The results revealed that rats treated with paraquat showed a significant increase in Lipid Peroxidation Oxidation (LPO) levels compared to the control group and those treated with NAC. However, treatment with nanoparaquat α and β resulted in a decrease in LPO levels compared to the paraquat-treated group. Additionally, when nanoparaquat α and β were administered in combination with NAC, a further reduction in LPO levels was observed compared to the PQ treated group. Regarding TAC levels, the PQ group exhibited a significant decrease compared to the control group and the NAC-treated group. However, treatment with nanoparaquat β resulted in higher TAC levels compared to the PQ group. Moreover, when nanoparaquat α and β were administered in combination with NAC, there was an increase in TAC levels compared to the PQ group. In terms of TTG levels, the PQ group showed a significant decrease compared to the control group and the NAC group. However, treatment with nanoparaquat β led to an increase in TTG levels compared to the PQ group. Furthermore, when nanoparaquat α and β were administered in combination with NAC, there was an increase in TTG levels compared to the PQ group. Overall, the results suggest that treatment with nanoparaquat, especially nanoparaquat β, may have a protective effect against oxidative stress induced by PQ toxicity in the kidney tissue of rats. Further studies are warranted to elucidate the underlying mechanisms and potential therapeutic implications of nanoparaquat in oxidative stress-related kidney disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.